Lv11
50 积分 2024-01-19 加入
Venetoclax adverse event monitoring: a safety meta-analysis of randomized controlled trials and a retrospective evaluation of the FAERS
11天前
已完结
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database
12天前
已完结
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for Bruton’s tyrosine kinase inhibitors (BTKis) single and its combination therapy
12天前
已完结
Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
2个月前
已完结
Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
2个月前
已关闭
Update on the Development of MNK Inhibitors as Therapeutic Agents
3个月前
已完结
Hypercalcemia as a clinical prodrome to lymphoma
3个月前
已关闭
Pharmacological reactivation of p53 in the era of precision anticancer medicine
3个月前
已完结
Translating p53-based therapies for cancer into the clinic
3个月前
已完结
Blocking smoothened cholesterylation: A strategy for overcoming drug resistance in cancer
3个月前
已完结
Predicting Malignant Lymph Nodes Using a Novel Scoring System Based on Multi-Endobronchial Ultrasound Features
Manipulation and (Mis)trust in Prediction Markets
皖公网安备34019202002308
